1. 1. WHO Blood Regulators Network (2017) Position Paper on Use of Convalescent Plasma, Serum of Immune Globuline Concentrates as an Element in Responseto an Emerging Virus.: https://cdn.who.int/media/docs/default-source/biologicals/blood-products/2017_brn_positionpaper_convalescentplasma.pdf?sfvrsn=ac8593c4_1&download=true
2. 2. WHO Blood Regulators Network (BRN), "Interim Position Paper on blood regulatory reponse to the evolving out-break of the 2019 novel coronavirus SARS-CoV-2." Available from: http://www.transfusion.ru/2020/04-03-3.pdf
3. 3. Immun-konvalesan-plazma tedarik ve klinik kullanim rehberi. Available from: https://shgmkanhizmetleridb.saglik.gov.tr/TR-72136/COVID-19-immun-konvalesan-plazma-tedarik-ve-klinik-kullanim-rehberi-guncellendi.html
4. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma;Salazar;Am J Pathol,2020
5. Immune reactivity during COVID-19: Implications for treatment;Napoli;Immunol Lett,2021